Loading clinical trials...
Loading clinical trials...
This trial aims to assess efficacy and safety of an intraperitoneal, aerosol, high-pressure chemotherapy in women with recurrent ovarian cancer
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ruhr University of Bochum
NCT05942300 · Recurrent Ovarian Cancer
NCT05335993 · Recurrent Ovarian Cancer, Recurrent Epithelial Cancer of Ovary, and more
NCT05126342 · Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, and more
NCT06257758 · Advanced or Metastatic Solid Tumors, Breast Cancer, and more
NCT03632798 · Recurrent Ovarian Cancer
Ruhr University Bochum
Bochum, North Rhine-Westphalia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions